Share the Video:

Visionary approaches: psychedelic policy in a global context

Steve Rolles, Kasia Malinowska

While international drug policy has historically tended to mirror that of the United States’ prohibitionist approach, times are changing – and we are ready to change, too. This conversation will situate psychedelic policy changes in context of broader drug policy reform, propose regulatory solutions, and offer a path forward for a unified approach toward a post-prohibition world. Don’t miss this superstar lineup of long-time leaders in global reform!

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Building momentum for new state policy approaches

Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.

Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd

PS2023 Health Equity Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Psychedelic social equity, criminal justice, and sentencing reform

Visionary advocates, activists, and policy experts discuss rectifying historical injustices and disparities from psychedelic criminalization. Conversations focus on social equity, criminal justice reform, and sentencing for legal infrastructure changes.

Kellen Russoniello, Rachel Knox, Sia Henry

PS2023 Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Designing a post-prohibition future

Harms of drug prohibition include trauma and research prevention. Policies should shift focus from criminalizing psychedelics to supporting safe, beneficial use, fostering an imaginative world for future generations.

Ariel Clark, Christopher Medina-Kirchner, Roman Haferd, Betty Aldworth, Paula Graciela Kahn

PS2023 Harm Reduction Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Proactive harm reduction by preparing set, setting, and substance

Harm reduction superheroes delve into risk mitigation and benefit maximization, exploring mindset, setting, and substances for safer drug experiences and systemic change.

Mitchell Gomez, Phoenix aka Mohawk Greene

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Research and Science

Updates from leading statewide regulatory initiatives - Oregon

Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are pioneering successful statewide initiatives regulating adult psychedelic substance use, influencing drug policy reforms in eleven other states in 2023.

Angela E Albee, Sam Chapman

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Research and Science

Updates from leading statewide regulatory initiatives - Colorado

Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are pioneering successful statewide initiatives regulating adult psychedelic substance use. Leaders discuss challenges and lessons learned in implementation.

Rev Veronica Lightning Horse P…, Ean Seeb, Hadas Alterman

PS2023 Healing for All Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

State Policy Reform: A Vision for Expanding Access to Psychedelics

Graham Boyd highlights recent ballot victories in Oregon and Colorado, emphasizing the potential for broad psychedelic access and significant policy reform advancements across the United States. Boyd discusses state legislatures'

Graham Boyd

PS2023 Harm Reduction Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Giving and growth: the role of philanthropic funding in the psychedelic sector

Philanthropy and investors can support crucial psychedelic research and initiatives beyond commercial interests to shape the field and promote equity and social value in the psychedelic economy.

Sandy Samberg

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social Justice

TREAT CALIFORNIA-Providing $5 Billion to Fund Psychedelic Research and Therapies

TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.

Jeannie Moller Fontana

Visionary approaches: psychedelic policy in a global context

Become a MAPS Member with a monthly donation

Related Videos